Page last updated: 2024-11-07

norethindrone acetate and Activated Protein C Resistance

norethindrone acetate has been researched along with Activated Protein C Resistance in 2 studies

norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.

Activated Protein C Resistance: A hemostatic disorder characterized by a poor anticoagulant response to activated protein C (APC). The activated form of Factor V (Factor Va) is more slowly degraded by activated protein C. Factor V Leiden mutation (R506Q) is the most common cause of APC resistance.

Research Excerpts

ExcerptRelevanceReference
" The aims of the present study were to evaluate a possible dose-response relationship and differential effects of different HT regimens on functionality of the APC system."2.73Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. ( Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eilertsen, AL1
Liestøl, S1
Mowinckel, MC2
Hemker, HC1
Sandset, PM2
Høibraaten, E1
de Ronde, H1
Bertina, RM1

Trials

2 trials available for norethindrone acetate and Activated Protein C Resistance

ArticleYear
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:6

    Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship,

2007
Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.
    British journal of haematology, 2001, Volume: 115, Issue:2

    Topics: Activated Protein C Resistance; Aged; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Re

2001